378 related articles for article (PubMed ID: 33941653)
21. MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex.
Fernandopulle NA; Zhang SS; Soeding PF; Mackay GA
Clin Exp Allergy; 2021 May; 51(5):685-695. PubMed ID: 33275825
[TBL] [Abstract][Full Text] [Related]
22. Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B
Roy S; Ganguly A; Haque M; Ali H
J Immunol; 2019 Feb; 202(4):1229-1238. PubMed ID: 30651343
[TBL] [Abstract][Full Text] [Related]
23. Quercetin inhibits Mrgprx2-induced pseudo-allergic reaction via PLCγ-IP3R related Ca
Ding Y; Che D; Li C; Cao J; Wang J; Ma P; Zhao T; An H; Zhang T
Int Immunopharmacol; 2019 Jan; 66():185-197. PubMed ID: 30471617
[TBL] [Abstract][Full Text] [Related]
24. Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2.
Zhang T; Che D; Liu R; Han S; Wang N; Zhan Y; Pundir P; Cao J; Lv Y; Yang L; Wang J; Ding M; Dong X; He L
Eur J Immunol; 2017 Nov; 47(11):1949-1958. PubMed ID: 28688196
[TBL] [Abstract][Full Text] [Related]
25. Substance P analogs devoid of key residues fail to activate human mast cells
Raj S; Hlushak S; Arizmendi N; Kovalenko A; Kulka M
Front Immunol; 2023; 14():1155740. PubMed ID: 37228611
[TBL] [Abstract][Full Text] [Related]
26. Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner with Further Support from JNK.
Babina M; Wang Z; Franke K; Zuberbier T
Cells; 2021 Jan; 10(1):. PubMed ID: 33429916
[TBL] [Abstract][Full Text] [Related]
27. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.
Navinés-Ferrer A; Serrano-Candelas E; Lafuente A; Muñoz-Cano R; Martín M; Gastaminza G
Sci Rep; 2018 Aug; 8(1):11628. PubMed ID: 30072729
[TBL] [Abstract][Full Text] [Related]
28. Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2.
Che D; Rui L; Cao J; Wang J; Zhang Y; Ding Y; Zhao T; Ma P; An H; Gao Z; Zhang T
Int Immunopharmacol; 2018 Sep; 62():244-250. PubMed ID: 30032049
[TBL] [Abstract][Full Text] [Related]
29. MRGPRX2 is critical for clozapine induced pseudo-allergic reactions.
Wei D; Hu T; Hou YJ; Wang XJ; Lu JY; Ge S; Wang C; He HZ
Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):77-84. PubMed ID: 33327824
[TBL] [Abstract][Full Text] [Related]
30. MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions.
Liu R; Che D; Zhao T; Pundir P; Cao J; Lv Y; Wang J; Ma P; Fu J; Wang N; Wang X; Zhang T; Dong X; He L
Biochem Pharmacol; 2017 Dec; 146():214-223. PubMed ID: 28987593
[TBL] [Abstract][Full Text] [Related]
31. Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization.
Subramanian H; Gupta K; Guo Q; Price R; Ali H
J Biol Chem; 2011 Dec; 286(52):44739-49. PubMed ID: 22069323
[TBL] [Abstract][Full Text] [Related]
32. Positive and Negative Signals in Mast Cell Activation.
Bulfone-Paus S; Nilsson G; Draber P; Blank U; Levi-Schaffer F
Trends Immunol; 2017 Sep; 38(9):657-667. PubMed ID: 28254170
[TBL] [Abstract][Full Text] [Related]
33. MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcεRI-mediated events.
Baldo BA
Br J Clin Pharmacol; 2023 Nov; 89(11):3232-3246. PubMed ID: 37430437
[TBL] [Abstract][Full Text] [Related]
34. MrgX2‑mediated internalization of LL‑37 and degranulation of human LAD2 mast cells.
Murakami T; Suzuki K; Niyonsaba F; Tada H; Reich J; Tamura H; Nagaoka I
Mol Med Rep; 2018 Dec; 18(6):4951-4959. PubMed ID: 30280189
[TBL] [Abstract][Full Text] [Related]
35. New insight into prurigo nodularis: Proadrenomedullin N-terminal 20 peptide mediates mouse mast cell activation via Mrgprb2.
Shao Y; Xiao Z; Jin Y; Zhu Y; Shen Y; Jin T; Tang H; Wang D
Skin Res Technol; 2024 Feb; 30(2):e13588. PubMed ID: 38284237
[TBL] [Abstract][Full Text] [Related]
36. Modulation of cell adhesion and motility in the immune system by Myo1f.
Kim SV; Mehal WZ; Dong X; Heinrich V; Pypaert M; Mellman I; Dembo M; Mooseker MS; Wu D; Flavell RA
Science; 2006 Oct; 314(5796):136-9. PubMed ID: 17023661
[TBL] [Abstract][Full Text] [Related]
37. Unlocking the Non-IgE-Mediated Pseudo-Allergic Reaction Puzzle with Mas-Related G-Protein Coupled Receptor Member X2 (MRGPRX2).
Kumar M; Duraisamy K; Chow BK
Cells; 2021 Apr; 10(5):. PubMed ID: 33925682
[TBL] [Abstract][Full Text] [Related]
38. Emerging Roles for MAS-Related G Protein-Coupled Receptor-X2 in Host Defense Peptide, Opioid, and Neuropeptide-Mediated Inflammatory Reactions.
Ali H
Adv Immunol; 2017; 136():123-162. PubMed ID: 28950944
[TBL] [Abstract][Full Text] [Related]
39. A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice.
Wolf K; Kühn H; Boehm F; Gebhardt L; Glaudo M; Agelopoulos K; Ständer S; Ectors P; Zahn D; Riedel YK; Thimm D; Müller CE; Kretschmann S; Kremer AN; Chien D; Limjunyawong N; Peng Q; Dong X; Kolkhir P; Scheffel J; Søgaard ML; Weigmann B; Neurath MF; Hawro T; Metz M; Fischer MJM; Kremer AE
J Allergy Clin Immunol; 2021 Aug; 148(2):506-522.e8. PubMed ID: 33617860
[TBL] [Abstract][Full Text] [Related]
40. Novel small molecule MRGPRX2 antagonists inhibit a murine model of allergic reaction.
Kumar M; Duraisamy K; Annapureddy RR; Chan CB; Chow BKC
J Allergy Clin Immunol; 2023 Apr; 151(4):1110-1122. PubMed ID: 36581009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
